New York Assembly Bill A08374

New York 2025-2026 Regular Session

• Introduced: 5/13/25
• Refer: 5/13/25
• Report Pass: 5/28/25
• Refer: 5/28/25
• Report Pass: 6/6/25
• Refer: 6/6/25
• Report Pass: 6/9/25
• Engrossed: 6/9/25
• Refer: 6/9/25
• Engrossed: 6/12/25
• Enrolled: 8/22/25
• Chaptered: 8/26/25
• Passed: 8/26/25

Caption

Authorizes the dormitory authority to provide financing to SB Clinical Practice Management Plan, Inc. for the construction of facilities.

Summary

A08374 amends New York’s Public Authorities Law to authorize the Dormitory Authority of the State of New York (DASNY) to provide financing or refinancing to SB Clinical Practice Management Plan, Inc. for the construction of facilities, specifically up to four advanced specialty care centers. The bill adds SB Clinical Practice Management Plan, Inc. to the list of entities eligible for DASNY financing under sections 1676 and 1680 of the law. In practical terms, the measure creates a statutory pathway for this private or affiliated clinical management entity to access public-authority financing tools that are typically used for capital projects such as health care, educational, or other public-purpose facilities. The bill takes effect immediately and does not itself appropriate funds, but it expands the scope of projects and borrowers that DASNY may support under existing law.

Impact

The bill directly amends the Public Authorities Law by inserting SB Clinical Practice Management Plan, Inc. into DASNY’s financing authorization provisions, thereby allowing the authority to issue or support financing for up to four advanced specialty care centers. This affects the legal powers of DASNY and the financing options available to the named entity for facility construction or refinancing, while leaving other state laws unchanged. The practical impact is on capital development and refinancing for specialty medical facilities, potentially influencing health care infrastructure and access in the state.

Sentiment

The available voting record shows strong, unanimous support at every stage, with no recorded opposition in committee or on the floor. The bill passed the Assembly committees, the Assembly floor, and the Senate floor by wide margins, indicating broad bipartisan or at least noncontroversial support. No committee transcripts were provided, but the vote pattern suggests the measure was viewed as routine or beneficial.

Contention

There is little evidence of substantive contention in the available record. The only likely point of policy interest is the use of a public authority financing mechanism for a specific named clinical practice management entity, which can sometimes raise questions about whether the project serves a sufficient public purpose or whether special financing treatment is appropriate. However, the unanimous votes indicate that any such concerns were not significant enough to generate recorded opposition.